Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTorres, M J-
dc.contributor.authorRomano, A-
dc.contributor.authorCelik, G-
dc.contributor.authorDemoly, P-
dc.contributor.authorKhan, D A-
dc.contributor.authorMacy, E-
dc.contributor.authorPark, M-
dc.contributor.authorBlumenthal, K-
dc.contributor.authorAberer, W-
dc.contributor.authorCastells, M-
dc.contributor.authorBarbaud, A-
dc.contributor.authorMayorga, C-
dc.contributor.authorBonadonna, P-
dc.identifier.citationTorres MJ, Romano A, Celik G, Demoly P, Khan DA, Macy E, et al. Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America. Clin Transl Allergy. 2017; 13;7:7.es_ES
dc.identifier.issn2045-7022 (Online)es_ES
dc.description.abstractDrug hypersensitivity reactions (DHRs) affect an unknown proportion of the general population, and are an important public health problem due to their potential to cause life-threatening anaphylaxis and rare severe cutaneous allergic reactions. DHR evaluations are frequently needed in both ambulatory and hospital settings and have a complex diagnosis that requires a detailed clinical history and other tests that may include in vitro tests and in vivo procedures such as skin tests and drug provocation tests. Although over the years both European and U.S. experts have published statements on general procedures for evaluating DHRs, a substantial discordance in their daily management exists. In this review, we highlight both the differences and the similarities between the European and U.S.es_ES
dc.publisherBiomed Centrales_ES
dc.relation.ispartofClinical and Translational Allergyes_ES
dc.rightsAn error occurred on the license name.*
dc.rights.uriAn error occurred getting the license - uri.*
dc.subjectSkin testes_ES
dc.subjectIn vitro testes_ES
dc.subjectDrug provocation testes_ES
dc.subjectUnit Stateses_ES
dc.subjectEvaluación de Medicamentoses_ES
dc.subjectHipersensibilidad a las drogases_ES
dc.subjectGrupos étnicoses_ES
dc.subjectSalud públicaes_ES
dc.subjectPruebas cutáneases_ES
dc.subjectEstados Unidoses_ES
dc.subject.meshMedical Subject Headings::Diseases::Immune System Diseases::Hypersensitivity::Hypersensitivity, Immediate::Anaphylaxises_ES
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Evaluation Studies as Topic::Drug Evaluationes_ES
dc.subject.meshMedical Subject Headings::Diseases::Chemically-Induced Disorders::Drug-Related Side Effects and Adverse Reactions::Drug Hypersensitivityes_ES
dc.subject.meshMedical Subject Headings::Health Care::Population Characteristics::Demography::Ethnic Groupses_ES
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses_ES
dc.subject.meshMedical Subject Headings::Health Care::Population Characteristics::Health::Public Healthes_ES
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Clinical Laboratory Techniques::Immunologic Tests::Skin Testses_ES
dc.subject.meshMedical Subject Headings::Geographical Locations::Geographic Locations::Americas::North America::United Stateses_ES
dc.subject.meshMedical Subject Headings::Geographical Locations::Geographic Locations::Europees_ES
dc.titleApproach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North Americaes_ES
dc.rights.accessRightsAcceso abiertoes_ES
dc.contributor.authoraffiliation[Torres,MJ; Mayorga,] Allergy Unit, National Network ARADyAL, IBIMA-Regional University Hospital of Malaga-UMA, Malaga, Spain. [Torres,MJ] BIONAND-Andalusian Centre for Nanomedicine and Biotechnology, Malaga, Spain. [Romano,A] Allergy Unit, Presidio Columbus, Rome, Italy. IRCCS Oasi Maria S.S., Troina, Italy. [Celik,G] Department of Chest Diseases, Division of Immunology and Allergy, Ankara University School of Medicine, Ankara, Turkey. [Demoly,P] Hôpital Arnaud de Villeneuve, University Hospital of Montpellier and Sorbonne Universités, UPMC Paris , IPLESP, Equipe EPAR, Paris, France. [Khan,DA] Department of Internal Medicine, Division of Allergy and Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA. [Macy,E] Kaiser Permanente Health Care Program, San Diego, CA, USA. [Park,M] Mayo Clinic College of Medicine, Division of Allergic Diseases, Mayo Clinic, Rochester, MN , USA. [Blumenthal,K] Division of Rheumatology, Allergy and Immunology, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. [Aberer,W] Department of Dermatology, Medical University of Graz, Graz, Austria. [Castells,M] Division of Rheumatology, Immunology and Allergy, Brigham and Women’s Hospital, Boston, MSA, USA. [Barbaud,A] Sorbonne Universities, UPMC Univ Paris, Dermatology and Allergology Department, Tenon Hospital (AP-HP), Paris, France. [Allergy Unit, IBIMA-Regional University Hospital of Malaga-UMA (Pavilion C) Malaga, Spain. [Bonadonna,P] Allergy Unit, Azienda Ospedaliera Universitaria Intergrata of Verona, Verona, Italy.es_ES
dc.type.subtypeArtículo originales_ES
Appears in Collections:01- Artículos - BIONAND - Centro Andaluz de Nanomedicina y Biotecnología
01- Artículos - Hospital Regional de Málaga
01- Artículos - IBIMA. Instituto de Investigación Biomédica de Málaga

Files in This Item:
File Description SizeFormat 
TorresMJ_ApproachToTheDiagnosis.pdfArtículo publicado974,78 kBAdobe PDFView/Open

This item is protected by original copyright

This item is licensed under a Creative Commons License Creative Commons